American Pharmacy News
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • Home
  • »
  • Stories
  • »
  • 2017

CMS offers resources to expand pharmacy care

American Pharmacy News Reports | Feb 12, 2017
Pharmacies are not required to use the new bulletin to maintain Medicaid and Medicare reimbursements.

The Center for Medicaid and CHIP Services is encouraging pharmacies to extend the scope of dispensing medications to foster immediate access to certain drugs.   Read More »

Eli Lilly updates label for Trulicity

American Pharmacy News Reports | Feb 12, 2017
Eli Lilly also stated Trucility is not a replacement for insulin.

Eli Lilly & Co. has updated the label of Trulicity, a drug used to help control Type 2 diabetes, to state that the drug may be used in combination with insulin. Read More »

sPCMA Business Forum to address key industry topics

American Pharmacy News Reports | Feb 12, 2017
Those panelists and more will debate the high price of drugs and other industry issues.

The sPCMA Business Forum will be held March 8-9, providing valuable information into specialty drug benefit management, specialty pharmacies, drug manufacturers and related topics.  Read More »

U.S. Supreme Court to review California ruling against pharmaceutical firm

John Breslin | Feb 13, 2017
The California Supreme Court's ruling against Bristol-Myers-Squibb will be reviewed by the U.S. Supreme Court.

Pharmaceutical companies, trial lawyers and tort reform advocates are closely following a case that the U.S. Supreme Court has taken up that addresses the issue of plaintiffs joining suits in other states. Read More »

Express Scripts: PBMs' "put medicine within reach for payers and patients"

Vimbai Chikomo | Feb 13, 2017
Between 2008 and 2016, average list prices for a market basket of the most commonly used brand name drugs increased 208 percent.

The listed price for brand-name drugs increased 11 percent last year, but the largest pharmacy benefits manager in the U.S. said it shielded employers it works with from the bulk of that increase. Read More »

Critics worry Trump will undo FDA safeguards

American Pharmacy News Reports | Feb 14, 2017
Jim O’Neill is the leading candidate to head FDA.

Soem critics argue that decades of U.S. Food and Drug Administration safeguards could be in jeopardy with President Donald Trump’s pick for head of the FDA. Read More »

Manufacturer says blood pressure machines meet CDC guidelines

American Pharmacy News Reports | Feb 14, 2017
Kiosk machines must have software that directly transfers results to the pharmacist.

PharmaSmart International, a specialist in blood pressure kiosks, announced that its machines meet new Centers for Disease Control guidelines. Read More »

Generic alliance rebrands as Association for Accessible Medicines to improve access

American Pharmacy News Reports | Feb 15, 2017
Generic alliance rebrands as Association for Accessible Medicines to improve access

The newly rebranded Association for Accessible Medicines (AAM) recently launched a nationwide campaign with the mission of 'Keeping Medicines in Reach,' sharing patient profiles and maintaining its vision to control existing drug costs. Read More »

Appeals court lifts injunction on Praluent

American Pharmacy News Reports | Feb 15, 2017
Regeneron is challenging both the injunction ruling and the validity of the appeal process.

A U.S. appeals court suspended a permanent injunction on Praluent, a cholesterol management drug, allowing Regeneron Pharmaceuticals to once again manufacture, market, sell and ship the drug around the world. Read More »

Anticoagulant medicine clears FDA mid-cycle review

American Pharmacy News Reports | Feb 15, 2017
Betrixaban is an anticoagulant medication used for patients with VTE.

Portola Pharmaceuticals cleared a U.S. Food and Drug Administration mid-cycle review for its new drug Betrixaban, meaning the drug will not have to go before an advisory committee at this stage. Read More »

FDA approves Parsabiv for adults with kidney failure

American Pharmacy News Reports | Feb 15, 2017
The number of people suffering from HPT has nearly doubled in the last five years.

The U.S. Food and Drug Administration approved Amgen's Parsabiv for the treating of secondary hyperparathyroidism in adults with chronic kidney failure and is administered at dialysis locations throughout the country. Read More »

Biogen presents at Global Healthcare Conference

American Pharmacy News Reports | Feb 15, 2017
Those who were unable to participate in the live event are encouraged to visit www.biogen.com/investors.

Biotechnology group Biogen presented this afternoon at the Leerink Partners' 6th Annual Global Healthcare Conference in New York. Read More »

45 million U.S. adults didn’t fill a prescription in 2016 due to cost

American Pharmacy News Reports | Feb 15, 2017
Eighteen percent of Americans over the age of 18 did not fill a prescription due to cost last year.

High prescription drug costs mean approximately 45 million adults in the U.S., or 18 percent of Americans over the age of 18, did not fill a prescription last year, according to the nonprofit group Prescription Justice.. Read More »

Lifes2good’s Berkeley Life Heart Health now available nationwide

American Pharmacy News Reports | Feb 15, 2017
Berkeley Life Heart Health Supplements come with test strips to test nitric oxide levels.

Lifes2good's new Berkeley Life Heart Health supplement, distributed by L2G North America Inc., is now available at Vitamin Shoppe and GNC stores across the country. Read More »

CMS nominee Verma backs PBMs in Medicare Part D

LocalLabs News Service | Feb 16, 2017
Seema Verma, nominee to head the Centers for Medicare and Medicaid Services, testifies before the U.S. Senate Finance Committee, 2/16/17

"I'm thankful that we have the PBMs in the Part D program that are performing that negotiation on behalf of seniors." -- Seema Verma, nominee to serve as administrator of the Centers for Medicare and Medicaid Services Read More »

RXi Pharmaceuticals names Kiessling to Scientific Advisory Board

American Pharmacy News Reports | Feb 16, 2017
Dr. Rolf Kiessling is also accredited with the discovery for Natural Killer cells in the mid-1970s.

RXi Pharmaceuticals Corp. has named Dr. Rolf Kiessling, professor in experimental oncology at Karolinska Institutet, to its Scientific Advisory Board. Read More »

Spartanburg County receives antidote for opioid overdose

American Pharmacy News Reports | Feb 16, 2017
Smith Drug Co.'s donation of 60 Opiate Overdose Kits will be shared throughout the Spartanburg County.

Spartanburg County, South Carolina has received a donation of opioid antidote.  Read More »

Mark Jackson to take over at VP Quality for Noven

American Pharmacy News Reports | Feb 17, 2017
Mark Jackson will be tasked with managing every company action related to quality assurance.

Mark Jackson has been appointed vice president of Quality for Noven Pharmaceuticals Inc. Read More »

Hennessey joins NQF's Medicaid Innovation Accelerator Project

American Pharmacy News Reports | Feb 17, 2017
Precision for Value's Maureen Hennessey has been appointed to NQF's Medicaid Innovation Accelerator Project.

Precision for Value has named Dr. Maureen Hennessey, senior vice president and director of quality and population health systems, to the National Quality Forum’s Medicaid Innovation Accelerator Project 2016-2017. Read More »

Sandoz aims to double sales in Japan by 2022

American Pharmacy News Reports | Feb 17, 2017
Japan hopes to raise generic medicine share to 80 percent by 2020.

Sandoz, a Novartis Division, recently announced plans to double sales in Japan over the 2015 to 2022 period as part of a grander, longterm strategy to deliver better access to high quality medicines to the nation. Read More »

  • «
  • 1
  • 2
  • ...
  • 5
  • 6
  • 7 (current)
  • 8
  • 9
  • ...
  • 36
  • 37
  • »
Trending

 B. Douglas Hoey CEO

NCPA releases new "Show Me" episodes about maternal vaccination programs

 Jeff Harrell Board President

NCPA reacts to Trump's drug pricing executive order targeting pharmacy benefit managers

 Jeff Harrell Board President

Arkansas law bans PBMs from pharmacy ownership to curb anti-competitive practices

John Kirtley Executive Director at Arkansas State Board of Pharmacy

Women's health block party to launch National Women's Health Month at Arkansas State Capitol

Copyright © 2025 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up